Advertisement
News
Advertisement

Atrial fibrillation: nContact wins FDA clearance for cardiac device

Wed, 01/23/2013 - 5:00am
Mass Device

nContact gets a nod from the FDA for its next-generation cardiac device with added sensing technology.

nContact logo

nContact said it's received FDA clearance for modifications made to its cardiac ablation device.

The Research Triangle Park, N.C.-based device medical device company won 510(k) clearance from the federal watchdog agency for the next generation of its VisiTrax cardiac ablation device, EPi-Sense. The company says this product includes new sensors, generating electrical feedback to assist electrophysiologists with device positioning during cardiac ablation procedures.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading